Organization
CVS Health
Owner of the CVS Caremark pharmacy benefit manager.
See FTC insulin case against the three largest PBMs and Pharmacy benefit manager market shares, 2025.
Connections 2
involved in
- FTC insulin case against the three largest PBMs Caremark: proposed consent order published 5 August 2026 Primary record 1
- Pharmacy benefit manager market shares, 2025 CVS Caremark Scholarship & press 2
Proof 2 sources
-
Caremark and Zinc Health Services; Analysis of Proposed Agreement Containing Consent Order To Aid Public Comment, Federal Register 91 FR (5 August 2026), U.S. Federal Trade Commission, 5 Aug 2026.
Primary record
The Complaint alleges that Caremark Respondents have engaged in anticompetitive and unfair rebating practices that artificially inflated the list price of insulin drugs
-
The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments (rerun), Drug Channels, 9 Jun 2026.
Scholarship & press
For 2025, 80% of all equivalent prescription claims were processed by three companies: the CVS Caremark business of CVS Health, the Express Scripts business of Cigna, and the Optum Rx business of UnitedHealth Group.
Page history 3 changes
- Second revision of Too Big to Fail: the FTC's 1917 finding, the 1952 report's seven firms, the 1984 hearing record, and corrected cards for Spirit, beef, tickets, Google and the final verdict05663c47
- Revise Too Big to Fail after the skeptic's review: read to 2 November 2026, a verdict card that separates findings from shares, the 1929 fight with its scandal and the board's stand, and sources for every cardc819f2cb
- Add the story Too Big to Fail: Standard Oil's stockholders, the phrase's origin in 1984, and market-by-market cases to November 2026aa9c434d
Something wrong or missing? Tell us, with a source, or edit this page.